{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:58Z","timestamp":1791704818060,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0552305"],"award-info":[{"award-number":["2025ZD0552305"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82541017"],"award-info":[{"award-number":["82541017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473106"],"award-info":[{"award-number":["82473106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103044","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:41:40Z","timestamp":1789994500000},"page":"103044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GMPS drives pancreatic cancer progression via suppressing DNA damage, STING activation and cellular senescence"],"prefix":"10.1016","volume":"73","author":[{"given":"Yangyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-8604","authenticated-orcid":false,"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103044_bib0001","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.103044_bib0002","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/annonc\/mdt239","article-title":"Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer","volume":"24","author":"Heinemann","year":"2013","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.tranon.2026.103044_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41575-023-00856-2","article-title":"Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer","volume":"21","author":"Stoop","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tranon.2026.103044_bib0004","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1097\/JS9.0000000000001479","article-title":"Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study","volume":"110","author":"Guo","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.tranon.2026.103044_bib0005","article-title":"Advances in the management of pancreatic cancer","volume":"383","author":"Del Chiaro","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.tranon.2026.103044_bib0006","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2026.103044_bib0007","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103044_bib0008","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa2505783","article-title":"Daraxonrasib in previously treated advanced RAS-mutated pancreatic cancer","volume":"394","author":"Wolpin","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103044_bib0009","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103044_bib0010","first-page":"25","article-title":"Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment","author":"Ma","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103044_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101368","article-title":"Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects","volume":"103","author":"Zhang","year":"2025","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.tranon.2026.103044_bib0012","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.7150\/jca.116357","article-title":"Isoliquiritigenin inhibits colorectal cancer progression by targeting the FGFR4\/FASN mediated lipid metabolism pathway","volume":"16","author":"Zhai","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2026.103044_bib0013","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s41467-021-22173-5","article-title":"The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation","volume":"12","author":"Shang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103044_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216696","article-title":"Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy","volume":"587","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103044_bib0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","article-title":"Emerging mechanisms and promising approaches in pancreatic cancer metabolism","volume":"15","author":"Wu","year":"2024","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.103044_bib0016","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or Gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103044_bib0017","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/biom13091379","article-title":"GMP synthetase: allostery, structure, and function","volume":"13","author":"Ballut","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.tranon.2026.103044_bib0018","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/cdd.2015.47","article-title":"Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity","volume":"22","author":"Bianchi-Smiraglia","year":"2015","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.tranon.2026.103044_bib0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/path.6442","article-title":"Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinoma","volume":"266","author":"Yu","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.tranon.2026.103044_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/path.5665","article-title":"Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth","volume":"254","author":"Wang","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.tranon.2026.103044_bib0021","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5183","article-title":"Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3\/P53 pathway","volume":"58","author":"Wang","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tranon.2026.103044_bib0022","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/s41418-021-00762-7","article-title":"The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53","volume":"28","author":"Su","year":"2021","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.tranon.2026.103044_bib0023","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s13402-025-01078-1","article-title":"GMPS inhibits the proliferation and migration of non-small cell lung cancer via the regulation of the DNMT 1\/SERPINB2 axis","volume":"48","author":"Guo","year":"2025","journal-title":"Cell Oncol."},{"key":"10.1016\/j.tranon.2026.103044_bib0024","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molcel.2005.02.013","article-title":"GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7","volume":"17","author":"van der Knaap","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tranon.2026.103044_bib0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molcel.2013.12.017","article-title":"Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization","volume":"53","author":"Reddy","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tranon.2026.103044_bib0026","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molcel.2011.06.034","article-title":"Mechanism of USP7\/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase","volume":"44","author":"Faesen","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tranon.2026.103044_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12929-020-0625-7","article-title":"TRIM21-SERPINB5 aids GMPS repression to protect nasopharyngeal carcinoma cells from radiation-induced apoptosis","volume":"27","author":"Zhang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tranon.2026.103044_bib0028","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends. Cell Biol."},{"key":"10.1016\/j.tranon.2026.103044_bib0029","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tranon.2026.103044_bib0030","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu2339","article-title":"TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer","volume":"11","author":"Urbach","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tranon.2026.103044_bib0031","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41418-024-01432-0","article-title":"A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma","volume":"32","author":"Guo","year":"2025","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.tranon.2026.103044_bib0032","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.devcel.2022.06.003","article-title":"Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD","volume":"57","author":"Donne","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tranon.2026.103044_bib0033","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41419-025-08061-6","article-title":"ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer","volume":"17","author":"Li","year":"2025","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.103044_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-336235","article-title":"Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition","author":"Wu","year":"2026","journal-title":"Gut"},{"key":"10.1016\/j.tranon.2026.103044_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu2276","article-title":"The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage","volume":"11","author":"Efthymiou","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tranon.2026.103044_bib0036","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2026.103044_bib0037","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1093\/nar\/gkae233","article-title":"ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response","volume":"52","author":"Bakr","year":"2024","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.103044_bib0038","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41556-022-00894-z","article-title":"A non-canonical cGAS-STING-PERK pathway facilitates the translational program critical for senescence and organ fibrosis","volume":"24","author":"Zhang","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tranon.2026.103044_bib0039","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.20180139","article-title":"The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tranon.2026.103044_bib0040","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103044_bib0041","first-page":"360","article-title":"Cellular senescence in cancer: clinical detection and prognostic implications","volume":"41","author":"Domen","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.tranon.2026.103044_bib0042","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41573-024-01074-4","article-title":"Senescence as a therapeutic target in cancer and age-related diseases","volume":"24","author":"McHugh","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tranon.2026.103044_bib0043","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103044_bib0044","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/febs.16350","article-title":"Targeting cellular senescence with senotherapeutics: senolytics and senomorphics","volume":"290","author":"Zhang","year":"2023","journal-title":"FEBS. J."},{"key":"10.1016\/j.tranon.2026.103044_bib0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi2465","article-title":"Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation","volume":"9","author":"Xiang","year":"2023","journal-title":"Sci. Adv."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:30:57Z","timestamp":1791703857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S1936523326003803"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103044","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GMPS drives pancreatic cancer progression via suppressing DNA damage, STING activation and cellular senescence","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103044"}}